Eckert & Ziegler SE

EUZ

DE0005659700

Office Equipment

Real-time Estimate Tradegate Other stock markets 06:00:37 2024-04-24 am EDT			5-day change	1st Jan Change
37.06 ^EUR	-0.70%		+10.45%	-9.93%

Apr. 22	Eckert & Ziegler increases profit at the start of the year - targets confirmed	DP
Apr. 04	RLS Radiopharmacies Partners with Eckert & Ziegler SE to Expand Production of Gallium-68-Based Radiopharmaceuticals	CI

ECKERT & ZIEGLER : Hauck & Aufhauser gives a Buy rating

November 24, 2022 at 05:13 am EST

In a research note published by Alexander Galitsa, Hauck & Aufhauser advises its customers to buy the stock. The target price is unchanged at EUR 120.

Latest news about Eckert & Ziegler SE

Eckert & Ziegler increases profit at the start of the year - targets confirmed	Apr. 22	DP
RLS Radiopharmacies Partners with Eckert & Ziegler SE to Expand Production of Gallium-68-Based Radiopharmaceuticals	Apr. 04	CI
Transcript : Eckert & Ziegler Strahlen- und Medizintechnik AG, 2023 Earnings Call, Mar 22, 2024	Mar. 22
Eckert & Ziegler SE Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 22	CI
Eckert & Ziegler recovers - Dividend disappointed - 'Balance sheet strong'	Mar. 20	DP
Eckert & Ziegler cuts dividend in favor of investments	Mar. 20	DP
ECKERT & ZIEGLER : Receives a Buy rating from Hauck & Aufhauser	Mar. 20	ZD
Eckert & Ziegler plans further growth - dividend decreases significantly	Mar. 19	DP
Eckert & Ziegler Strahlen- und Medizintechnik AG(XTRA:EUZ) added to Germany TECDAX Index (Price Return)	Mar. 17	CI
Eckert & Ziegler Strahlen- und Medizintechnik AG(XTRA:EUZ) added to Germany TECDAX (Total Return) Index	Mar. 17	CI
Deutsche Börse's Stoxx to Make Changes to DAX Indices	Mar. 06	MT
Index changes move - MDax ejection weighs on Rational	Mar. 06	DP
ECKERT & ZIEGLER : Gets a Buy rating from Hauck & Aufhauser	Mar. 06	ZD
Eckert & Ziegler to Supply Nucleus RadioPharma with Therapeutic Radioisotopes Ac-225 and Lu-177	Jan. 31	CI
ECKERT & ZIEGLER : Hauck & Aufhauser gives a Buy rating	Jan. 03	ZD
ECKERT & ZIEGLER : Hauck & Aufhauser keeps its Buy rating	Dec. 07	ZD
Chairman of the Supervisory Board of Eckert & Ziegler moves to subsidiary Pentixapharm	Nov. 21	DP
Eckert & Ziegler AG Announces Executive Changes	Nov. 21	CI
ECKERT & ZIEGLER : Hauck & Aufhauser keeps its Buy rating	Nov. 20	ZD
Eckert & Ziegler Strahlen- und Medizintechnik AG Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 14	CI
ECKERT & ZIEGLER : Hauck & Aufhauser keeps its Buy rating	Nov. 08	ZD
Eckert & Ziegler shares continue upswing since the end of September	Nov. 08	DP
ECKERT & ZIEGLER : Hauck & Aufhauser reiterates its Buy rating	23-10-25	ZD
Global markets live: Foxconn, Roche, Eli Lilly, Chevron, Apple...	23-10-23
Eckert & Ziegler and Ablaze Pharmaceuticals Sign Comprehensive Supply Agreement for Non-Carrier Added Lutetium-177	23-10-23	CI

Eckert & Ziegler SE is a Germany-based Company, which is a provider of isotope technology for medical, scientific and industrial use with focus on cancer therapy, industrial radiometry and nuclear-medical imaging. The Company operates through three segments: Radiation Therapy, Isotope Products and Radiopharma. The Radiation Therapy segment operates through Eckert & Ziegler BEBIG and produces and distributes medical products for the treatment of cancer using brachytherapy. The Isotope Products segment provides sealed and unsealed radiation sources for medical imaging, industrial gauging, measurement and analysis, reference, calibration and environmental monitoring sources and solutions, as well as bulk radioisotopes for pharmaceutical, therapeutic and industrial product manufacturers. The Radiopharma segment specializes in molecular imaging and nuclear medicine, and supplies various radiopharmaceuticals, radiochemicals and related equipment.

Sector

Office Equipment

Calendar

2024-05-14 - Q1 2024 Earnings Release

More about the company

Income Statement Evolution

More financial data

Ratings for Eckert & Ziegler SE

Trading Rating

Investor Rating

ESG Refinitiv

C+

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

37.32 EUR

Average target price

60 EUR

Spread / Average Target

+60.77%

Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Scientific & Precision Equipment

	1st Jan change	Capi.
ECKERT & ZIEGLER SE	-9.93%	832M
SHIMADZU CORPORATION	+7.91%	7.9B
TECAN GROUP AG	-1.05%	4.74B
OLINK HOLDING AB	-11.69%	2.76B
JEOL LTD.	+6.69%	2.1B
NINGBO YONGXIN OPTICS CO.,LTD	-30.72%	1.06B
PARK SYSTEMS CORP.	-19.08%	708M
PHENIX OPTICAL COMPANY LIMITED	-26.01%	659M
FOCUSED PHOTONICS (HANGZHOU), INC.	-29.34%	694M
MLOPTIC CORP.	-58.27%	660M

Scientific & Precision Equipment

Eckert & Ziegler SE

Equities

EUZ

DE0005659700

Office Equipment

ECKERT & ZIEGLER : Hauck & Aufhauser gives a Buy rating

Latest news about Eckert & Ziegler SE

Chart Eckert & Ziegler SE

Company Profile

Income Statement Evolution

Ratings for Eckert & Ziegler SE

Analysts' Consensus

EPS Revisions

Annual profits - Rate of surprise

Sector Scientific & Precision Equipment